Skip to content

KHEOBA CORP.: 10-Q filed 2024-06-11

What KHEOBA CORP. reported in its quarterly report filed 2024-06-11 (fiscal Q2 2024): 21 published measures, 66 facts as tagged in accession 0001477932-24-003623.

This filing

Form
10-Q (quarterly report)
Filed
2024-06-11
Fiscal period
fiscal Q2 2024
Accession
0001477932-24-003623 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All KHEOBA CORP. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2024-04-3035,635USD
At 2023-10-3132,695USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2024-04-3031,265USD
At 2024-01-3142,127USD
At 2023-10-3122,488USD
At 2023-04-305,031USD
At 2023-01-31-3,365USD
At 2022-10-31-3,365USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2024-02-01 to 2024-04-30-10,862USD90
2023-11-01 to 2024-04-30-7,163USD182
2023-11-01 to 2024-01-313,699USD92
2023-02-01 to 2023-04-308,396USD89
2022-11-01 to 2023-04-308,396USD181
2022-11-01 to 2023-01-310USD92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2023-11-01 to 2024-04-30-18,333USD182
2022-11-01 to 2023-04-303,896USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2024-02-01 to 2024-04-300USD90
2023-11-01 to 2024-04-3010,300USD182
2023-02-01 to 2023-04-309,400USD89
2022-11-01 to 2023-04-309,400USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2023-11-01 to 2024-04-3015,940USD182
2022-11-01 to 2023-04-300USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2023-11-01 to 2024-04-30-13,000USD182
2022-11-01 to 2023-04-300USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2024-04-30-16,575USD
At 2023-10-31-9,412USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2024-02-01 to 2024-04-300USD90
2023-11-01 to 2024-04-300USD182
2023-02-01 to 2023-04-300USD89
2022-11-01 to 2023-04-300USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2024-02-01 to 2024-04-30-10,862USD90
2023-11-01 to 2024-04-30-7,163USD182
2023-02-01 to 2023-04-308,396USD89
2022-11-01 to 2023-04-308,396USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2024-04-3021,385USD
At 2023-10-3129,778USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2024-04-304,370USD
At 2023-10-3110,207USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2024-04-300USD
At 2023-10-312,537USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2024-02-01 to 2024-04-3010,862USD90
2023-11-01 to 2024-04-3017,463USD182
2023-02-01 to 2023-04-301,004USD89
2022-11-01 to 2023-04-301,004USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2024-04-308,092,000shares
At 2023-10-317,295,000shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2024-04-301,385USD
At 2023-10-3116,778USD
At 2023-04-305,901USD
At 2022-10-312,005USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2024-04-3039,748USD
At 2023-10-3124,605USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2024-02-01 to 2024-04-3010,862USD90
2023-11-01 to 2024-04-3017,463USD182
2023-02-01 to 2023-04-301,004USD89
2022-11-01 to 2023-04-301,004USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2023-11-01 to 2024-04-301,667USD182
2022-11-01 to 2023-04-300USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2023-11-01 to 2024-04-3015,940USD182
2023-12-01 to 2023-12-31840USD31
2023-11-01 to 2023-11-3015,100USD30
2023-10-01 to 2023-10-3117,360USD31
2023-09-01 to 2023-09-308,540USD30
2022-11-01 to 2023-04-300USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2023-11-01 to 2024-04-30-2,537USD182
2022-11-01 to 2023-04-30-4,500USD181

Inspect the source

Entity
KHEOBA CORP. / CIK 0001909770
Captured
2026-09-21T17:34:29.762Z
SEC response SHA-256
f0e6b689ed685010bcdab0d67d81c75dcccb68517c577ce43bc22cf2ace7d3f3

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001909770.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))